Dapagliflozin/saxagliptin - AstraZeneca
At a glance
- Drug Originator Bristol-Myers Squibb
- Drug Class Adamantanes; Antihyperglycaemics; Chlorobenzenes; Cycloparaffins; Dipeptides; Glucosides; Nitriles; Organic bridged compounds; Piperidines; Pyrans; Small molecules
- Mechanism of Action Dipeptidyl peptidase 4 inhibitors; Sodium-glucose transporter 2 inhibitors
- USA Patent Applicants ASTRAZENECA AB
- USA Patents 14
- NDAs 1
- International Patents 310
Table of Contents

Disclaimer